Synopsis of Key Gynecologic Oncology Trials
Auteurs : Renz Malte, Dorigo Oliver, Diver Elisabeth, Growdon Whitfield
This text is a fast and convenient overview of the clinical trials in gynecologic cancer treatment, setting out the evidence base of treatment decisions in uterine, ovarian, cervical and vulval cancers and gestational trophoblastic neoplasia. Residents and fellows will find this book an indispensable reference for revision, while existing practitioners will welcome it as a clarification of the evidence base for treatment options.
1. Uterine Malignancies. 2.Ovarian Malignancies. 3.Cervical Cancer. 4.Vulvar Cancer. 5.Gestational Trophoblastic Neoplasia. Glossary.
Malte Renz, MD, PhD: Division of Gynecologic Oncology, Stanford University School of Medicine, Stanford, California, USA
Elisabeth J. Diver, MD: Division of Gynecologic Oncology, Stanford University School of Medicine, Stanford, California, USA
Whitfield B. Growden, MD: Division of Obstetrics, Gynecology, and Reproductive Biology, Massachusetts General Hospital,Harvard University, Boston, Massachusetts, USA
Oliver Dorigo, MD, PhD: Division of Gynecologic Oncology, Stanford University School of Medicine, Standford, California, USA
Date de parution : 08-2019
13.8x21.6 cm
Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).
Prix indicatif 66,20 €
Ajouter au panierThèmes de Synopsis of Key Gynecologic Oncology Trials :
Mots-clés :
Carboplatin AUC; Median PFS; evidence base for cancer treatment; PD L1 Expression; gyn onc clinical trials; Platinum Sensitive Recurrent Ovarian Cancer; key cancer trials; Median Dor; cervical cancer; Isosulfan Blue; gestational trophoblastic neoplasia; SLN Biopsy; gynecologic cancer treatment; PD L1 Positive Tumor; ovarian malignancy; Deepest Tumor Penetration; clinical trial; Dose Dense Paclitaxel; oncology revision; Platinum Sensitive Ovarian Cancer; oncology primer; Vulvar Cancer; oncology boards primer; LN Metast